Pre-implantation genetic testing, or PGT, for rare genetic disorders and chromosomal abnormalities has become common practice in the 14 billion US dollar IVF industry. Testing for polygenic conditions, often referred to as PGTP, is much newer,. Only a small handful of companies selling it in a few countries, including the United States and Brazil. Many are troubled by the possibilities that PGTP presents.